跳至主要内容
临床试验/TCTR20230507001
TCTR20230507001已完成1 期

A STUDY OF SAFETY AND EFFICACY OF NUTRI-JELLY IN END STAGE RENAL DISEASE PATIENTS UNDERGOING HEMODIALYSIS A Single-blinded Randomized Controlled Trial.

Program in Toxicology and Nutrition for Food Safety0 个研究点目标入组 20 人开始时间: 2023年5月7日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • being diagnosed with ESRD patients undergoing hemodialysis for at least one year, Outpatients, On regular hemodialysis 3 times a week, HbA1c<9,
  • Acceptable to eat Nutri-jelly, Age 18-65 years old, Albumin 2.0-4.0 g/dl(>3.5g/dl), k+<6 mg/dl, Protein intake 0.50-0.70 g. per kg body weight: day (1.2g/ kg body weight: day), IBW 50-60 kg

排除标准

  • Medication to control electrolytes, Changing in medicine used, Primary parathyroid diseases, Active infection, Active malignancy, Heart failure, Pregnancy, Allergic to milk, egg, fish, shrimp, Complete nutrition formula intake, Personal use of dietary supplements (Not prescribed /recommended by physicians),
  • Being unable to make a reliable decision or effective communication

研究者

发起方
Program in Toxicology and Nutrition for Food Safety

相似试验